RESUMO
Fetal growth restriction arising from placental insufficiency is a leading cause of stillbirth. We recently identified low maternal circulating SPINT1 concentrations as a novel biomarker of poor fetal growth. Here we measured SPINT1 in a prospective cohort in Singapore. Circulating SPINT1 concentrations were significantly lower among 141 pregnant women destined to deliver small-for-gestational age infants (birthweight <10th centile), compared to 772 controls (p < 0.01) at as early as 26 weeks' gestation. There were no correlations between infant body composition and circulating SPINT1 concentrations at 26 weeks. This provides validation that low maternal SPINT1 concentration is associated with poor fetal growth.
Assuntos
Retardo do Crescimento Fetal/sangue , Insuficiência Placentária/sangue , Proteínas Secretadas Inibidoras de Proteinases/sangue , Adulto , Peso ao Nascer/fisiologia , Estudos de Casos e Controles , Estudos de Coortes , Regulação para Baixo , Feminino , Retardo do Crescimento Fetal/epidemiologia , Idade Gestacional , Humanos , Recém-Nascido , Recém-Nascido Pequeno para a Idade Gestacional , Avaliação de Resultados em Cuidados de Saúde , Insuficiência Placentária/epidemiologia , Gravidez , Resultado da Gravidez/epidemiologia , Segundo Trimestre da Gravidez/sangue , Proteínas Secretadas Inibidoras de Proteinases/análise , Singapura/epidemiologia , Natimorto/epidemiologiaRESUMO
OBJECTIVE: To demonstrate the feasibility of studying exosomes directly from peritoneal fluid, we isolated exosomes from endometriosis patient samples and from controls, and characterized their cargo. DESIGN: Case-control experimental study. SETTING: Academic clinical center. PATIENT (S): Women with and without endometriosis who underwent laparoscopic surgery (n = 28 in total). INTERVENTION (S): None. MAIN OUTCOME MEASURE (S): Concentration of exosomes within peritoneal fluid and protein content of the isolated exosomes. RESULT (S): Peritoneal fluid samples were pooled according to the cycle phase and disease stage to form six experimental groups, from which the exosomes were isolated. Exosomes were successfully isolated from peritoneal fluid in all the study groups. The concentration varied with cycle phase and disease stage. Proteomic analysis showed specific proteins in the exosomes derived from endometriosis patients that were absent in the controls. Five proteins were found exclusively in the endometriosis groups: PRDX1, H2A type 2-C, ANXA2, ITIH4, and the tubulin α-chain. CONCLUSION (S): Exosomes are present in peritoneal fluid. The characterization of endometriosis-specific exosomes opens up new avenues for the diagnosis and investigation of endometriosis.
Assuntos
Líquido Ascítico/química , Endometriose/metabolismo , Exossomos/química , Proteínas/análise , Adulto , Anexina A2/análise , Líquido Ascítico/patologia , Estudos de Casos e Controles , Endometriose/patologia , Exossomos/ultraestrutura , Estudos de Viabilidade , Feminino , Histonas/análise , Humanos , Pessoa de Meia-Idade , Peroxirredoxinas/análise , Proteínas Secretadas Inibidoras de Proteinases/análise , Proteômica , Tubulina (Proteína)/análise , Adulto JovemRESUMO
Progression from human papillomavirus-induced premalignant cervical intraepithelial neoplasia (CIN) to cervical cancer (CC) is driven by genetic and epigenetic events. Our microarray-based expression study has previously shown that inter-α-trypsin-inhibitor heavy chain 5 (ITIH5) mRNA levels in CCs were significantly lower than in high-grade precursor lesions (CIN3s). Therefore, we aimed to analyze in depth ITIH5 expression during cervical carcinogenesis in biopsy material and cell culture. Moreover, functional analyses were performed by ectopic expression of ITIH5 in different cell lines. We were able to confirm the validity of our microarray differential expression data by qPCR, demonstrating a clear ITIH5 downregulation in CC as compared with CIN2/3 or normal cervix. ITIH5 protein loss, evaluated by immunohistochemistry, was evident in 81% of CCs, whereas ITIH5 showed weak to moderate cytoplasmic staining in 91% of CIN2/3 cases. In addition, ITIH5 was strongly reduced or absent in seven CC cell lines and in three immortalized keratinocyte cell lines. Moreover, ITIH5 mRNA loss was associated with ITIH5 promoter methylation. ITIH5 expression could be restored in CC cell lines by pharmacological induction of DNA demethylation and histone acetylation. Functionally, ITIH5 overexpression significantly suppressed proliferation of SW756 cells and further resulted in a significant reduction of colony formation and cell migration in both CaSki and SW756 tumor models, but had no effect on invasion. Remarkably, ITIH5 overexpression did not influence the phenotype of HeLa cells. Taken together, ITIH5 gene silencing is a frequent event during disease progression, thereby providing evidence for a tumor suppressive role in cervical carcinogenesis.
Assuntos
Carcinogênese/genética , Regulação Neoplásica da Expressão Gênica , Genes Supressores de Tumor , Ovário/patologia , Proteínas Secretadas Inibidoras de Proteinases/genética , Neoplasias do Colo do Útero/genética , Carcinogênese/patologia , Linhagem Celular Tumoral , Movimento Celular , Proliferação de Células , Células Cultivadas , Metilação de DNA , Regulação para Baixo , Feminino , Genômica , Humanos , Ovário/metabolismo , Regiões Promotoras Genéticas , Proteínas Secretadas Inibidoras de Proteinases/análise , Neoplasias do Colo do Útero/patologiaRESUMO
Netherton syndrome (NS) is a severe genetic skin disorder, with often delayed or misleading clinical signs. The histological features of skin biopsies, usually described as a psoriasiform hyperplasia, have only been reported in isolated case reports or small case series. The aim of this study is to define, for the first time, the precise histological pattern of cutaneous lesions, in a large cohort of skin biopsies from confirmed NS patients. The study included 80 consecutive skin biopsies from 67 patients taken between January 1995 and June 2014. All were from confirmed NS patients with either a negative lympho-epithelial Kazal-type-related inhibitor (LEKTI) immunohistochemistry and/or molecular confirmation by identified mutation in SPINK5. In this cohort, the most frequent histological finding was also psoriasiform hyperplasia, but there were additional, less common, or previously unreported findings, including compact parakeratosis with large nuclei, subcorneum or intracorneum splitting, presence of clear cells in the upper epidermis or stratum corneum, dyskeratosis, dermal infiltrate with neutrophils and/or eosinophils, and dilated blood vessels in the superficial dermis. An early confirmation of the diagnosis of NS is essential for improved patient management. Thus, in the situation of a patient with an unknown skin disorder and non specific clinical presentation, the dermatopathologist may now be able to suggest the diagnosis of NS based on these newly reported characteristics. However, LEKTI immunohistochemistry remains the essential diagnostic investigation in cases with misleading or nonspecific histological features and is mandatory for the definitive diagnosis of NS in all patients.
Assuntos
Síndrome de Netherton/patologia , Pele/patologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Biópsia , Criança , Pré-Escolar , Análise Mutacional de DNA , Marcadores Genéticos , Predisposição Genética para Doença , Humanos , Imuno-Histoquímica , Lactente , Recém-Nascido , Pessoa de Meia-Idade , Mutação , Síndrome de Netherton/genética , Síndrome de Netherton/metabolismo , Fenótipo , Valor Preditivo dos Testes , Prognóstico , Proteínas Secretadas Inibidoras de Proteinases/análise , Proteínas Secretadas Inibidoras de Proteinases/genética , Estudos Retrospectivos , Inibidor de Serinopeptidase do Tipo Kazal 5 , Pele/química , Adulto JovemRESUMO
Inter-α-trypsin inhibitors are protease inhibitors that are thought to be important regulators in various acute-phase processes. They are composed of one light chain (bikunin) and different heavy chains (ITIHs). The only function known so far of ITIHs is the covalent linkage to hyaluronan (HA). As there is virtually no knowledge on the distribution and function of ITIH proteins in skin tissue, we performed a systematic characterization of ITIH expression in healthy and diseased skin. Using GeneChip(®) Human Exon 1.0 ST expression profiling, we found that ITIH5 represents the major ITIH family member expressed in human skin. Moreover, the use of quantitative reverse transcription PCR and a customized ITIH5-specific antibody indicated that ITIH5 is predominantly produced by dermal fibroblasts. Immunohistochemical analysis revealed a clearly detectable ITIH5 protein expression in normal skin. Interestingly, ITIH5 expression was significantly up-regulated in inflammatory skin diseases. Furthermore, 3D skin models employing murine Itih5(-/-) epidermal keratinocytes and dermal fibroblasts as well as skin specimens of Itih5(-/-) mice revealed a significantly altered epidermal structure compared to wild-type controls. Hence, we can strengthen the presumption that ITIH5 may constitute a novel regulatory molecule of the human skin that could play an important role in inflammation via its interaction with HA.
Assuntos
Epiderme/metabolismo , Expressão Gênica , Proteínas Secretadas Inibidoras de Proteinases/genética , Proteínas Secretadas Inibidoras de Proteinases/metabolismo , Dermatopatias/genética , Dermatopatias/metabolismo , alfa-Globulinas/genética , Animais , Proteínas Sanguíneas/genética , Células Cultivadas , Epiderme/química , Epiderme/patologia , Feminino , Fibroblastos , Perfilação da Expressão Gênica , Glicoproteínas/genética , Humanos , Ácido Hialurônico/metabolismo , Inflamação/genética , Queratinócitos , Camundongos , Camundongos Knockout , Modelos Anatômicos , Análise de Sequência com Séries de Oligonucleotídeos , Proteínas Secretadas Inibidoras de Proteinases/análise , RNA Mensageiro/metabolismo , Regulação para CimaRESUMO
Ichthyosis linearis circumflexa (ILC) presents as serpiginous and migratory erythematous patches with double-edged scales. ILC is rarely an isolated skin manifestation, but most commonly a part of Netherton syndrome (NS). NS is caused by SPINK5 mutations, which lead to absent or sometimes reduced expression of the serine protease inhibitor LEKTI. NS is characterised by congenital ichthyosiform erytroderma, trichorrhexis invaginata (TI) and atopy. We report 2 children who presented since the first months of life cheek erythema followed by the appearance of sparse ILC lesions on the face, trunk and proximal extremities. Erythroderma at birth, TI and atopy were absent. LEKTI immunoreactivity was reduced in patient epidermis, and serine protease activity was modestly increased, while desmoglein-1 expression remained unaffected. SPINK5 mutation and expression analysis in patient keratinocytes revealed compound heterozygous splicing variants, which allowed residual LEKTI secretion. Our results show that ILC can be the only clinical manifestation of NS.
Assuntos
Epiderme/química , Ictiose/etiologia , Síndrome de Netherton/complicações , Síndrome de Netherton/genética , Proteínas Secretadas Inibidoras de Proteinases/análise , Proteínas Secretadas Inibidoras de Proteinases/genética , Pré-Escolar , Desmogleína 1/análise , Epiderme/enzimologia , Feminino , Humanos , Lactente , Masculino , Mutação , Síndrome de Netherton/diagnóstico , Síndrome de Netherton/enzimologia , Inibidor de Serinopeptidase do Tipo Kazal 5 , Serina Proteases/metabolismoRESUMO
We provide the first comprehensive analysis of the extracellular matrix (ECM) composition of peri-islet capsules, composed of the peri-islet basement membrane (BM) and subjacent interstitial matrix (IM), in development of type 1 diabetes in NOD mice and in human type 1 diabetes. Our data demonstrate global loss of peri-islet BM and IM components only at sites of leukocyte infiltration into the islet. Stereological analyses reveal a correlation between incidence of insulitis and the number of islets showing loss of peri-islet BM versus islets with intact BMs, suggesting that leukocyte penetration of the peri-islet BM is a critical step. Protease- and protease inhibitor-specific microarray analyses (CLIP-CHIP) of laser-dissected leukocyte infiltrated and noninfiltrated pancreatic islets and confirmatory quantitative real time PCR and protein analyses identified cathepsin S, W, and C activity at sites of leukocyte penetration of the peri-islet BM in association with a macrophage subpopulation in NOD mice and human type 1 diabetic samples and, hence, potentially a novel therapeutic target specifically acting at the islet penetration stage. Interestingly, the peri-islet BM and underlying IM are reconstituted once inflammation subsides, indicating that the peri-islet BM-producing cells are not lost due to the inflammation, which has important ramifications to islet transplantation studies.
Assuntos
Membrana Basal/imunologia , Quimiotaxia de Leucócito/imunologia , Diabetes Mellitus Tipo 1/imunologia , Matriz Extracelular/imunologia , Ilhotas Pancreáticas/imunologia , Animais , Catepsina C/análise , Catepsina W/análise , Catepsinas/análise , Humanos , Inflamação/metabolismo , Ilhotas Pancreáticas/patologia , Macrófagos/imunologia , Macrófagos/patologia , Camundongos , Camundongos Endogâmicos NOD , Análise Serial de Proteínas , Proteínas Secretadas Inibidoras de Proteinases/análiseRESUMO
During plant-pathogen interaction, oomycetes secrete effectors into the plant apoplast where they interact with host resistance proteins, which are accumulated after wounding or infection. Previous studies showed that the expression profile of pathogenesis related proteins is proportional to the resistance of different cultivars toward Phytophthora infestans infection. The aim of this work was to analyze the expression pattern of apoplastic hydrophobic proteins (AHPs), after 24 h of wounding or infection, in tubers from two potato cultivars with different resistance to P. infestans, Spunta (susceptible) and Innovator (resistant). Intercellular washing fluid (IWF) was extracted from tubers and chromatographed into a PepRPC™ HR5-5 column in FPLC eluted with a linear gradient of 75% acetonitrile. Then, AHPs were analyzed by SDS-PAGE and identified by MALDI-TOF-MS. Innovator cv. showed a higher basal AHP content compared to Spunta cv. In the latter, infection induced accumulation of patatins and protease inhibitors (PIs), whereas in Innovator cv. no changes in PIs accumulation were observed. In response to P. infestans infection, lipoxygenase, enolase, annexin p34 and glutarredoxin/cyclophilin were accumulated in both cultivars. These results suggest that the AHPs content may be related to the protection against the oomycete and with the degree of potato resistance to pathogens. Additionally, a considerable number of the proteins putatively identified lacked the signal peptide and, being SecretomeP positive, suggest unconventional protein secretion.
Assuntos
Phytophthora infestans/patogenicidade , Doenças das Plantas/imunologia , Proteínas de Plantas/metabolismo , Proteínas Secretadas Inibidoras de Proteinases/metabolismo , Solanum tuberosum/metabolismo , Resistência à Doença , Eletroforese em Gel de Poliacrilamida , Regulação da Expressão Gênica de Plantas , Interações Hospedeiro-Patógeno , Interações Hidrofóbicas e Hidrofílicas , Doenças das Plantas/parasitologia , Proteínas de Plantas/análise , Proteínas de Plantas/isolamento & purificação , Tubérculos/imunologia , Tubérculos/metabolismo , Tubérculos/parasitologia , Proteínas Secretadas Inibidoras de Proteinases/análise , Proteômica , Solanum tuberosum/imunologia , Solanum tuberosum/parasitologia , Solanum tuberosum/fisiologia , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Ferimentos e LesõesRESUMO
In periodontitis, an effective host-response is primarily related to neutrophils loaded with serine proteases, including elastase (NE) and protease 3 (PR3), the extracellular activity of which is tightly controlled by endogenous inhibitors. In vitro these inhibitors are degraded by gingipains, cysteine proteases produced by Porphyromonas gingivalis. The purpose of this study was to determine the level of selected protease inhibitors in gingival crevicular fluid (GCF) in relation to periodontal infection. The GCF collected from 31 subjects (nine healthy controls, seven with gingivitis, five with aggressive periodontitis and 10 with chronic periodontitis) was analyzed for the levels of elafin and secretory leukocyte protease inhibitor (SLPI), two main tissue-derived inhibitors of neutrophil serine proteases. In parallel, activity of NE, PR3 and arginine-specific gingipains (Rgps) in GCF was measured. Finally loads of P. gingivalis, Aggregatibacter actinomycetemcomitans, Tannerella forsythia and Treponema denticola were determined. The highest values of elafin were found in aggressive periodontitis and the lowest in controls. The quantity of elafin correlated positively with the load of P. gingivalis, Ta. forsythia and Tr. denticola, as well as with Rgps activity. In addition, NE activity was positively associated with the counts of those bacterial species, but not with the amount of elafin. In contrast, the highest concentrations of SLPI were found in periodontally healthy subjects whereas amounts of this inhibitor were significantly decreased in patients infected with P. gingivalis. Periodontopathogenic bacteria stimulate the release of NE and PR3, which activities escape the control through degradation of locally produced inhibitors (SLPI and elafin) by host-derived and bacteria-derived proteases.
Assuntos
Periodontite Agressiva/enzimologia , Periodontite Crônica/enzimologia , Líquido do Sulco Gengival/enzimologia , Porphyromonas gingivalis/metabolismo , Proteínas Secretadas Inibidoras de Proteinases/metabolismo , Adesinas Bacterianas/metabolismo , Adulto , Aggregatibacter actinomycetemcomitans/isolamento & purificação , Aggregatibacter actinomycetemcomitans/metabolismo , Periodontite Agressiva/microbiologia , Bacteroides/isolamento & purificação , Bacteroides/metabolismo , Estudos de Casos e Controles , Periodontite Crônica/microbiologia , Cisteína Endopeptidases/metabolismo , Elafina/análise , Elafina/metabolismo , Feminino , Cisteína Endopeptidases Gingipaínas , Gengivite/enzimologia , Gengivite/microbiologia , Humanos , Masculino , Pessoa de Meia-Idade , Porphyromonas gingivalis/isolamento & purificação , Proteínas Secretadas Inibidoras de Proteinases/análise , Inibidor Secretado de Peptidases Leucocitárias/análise , Inibidor Secretado de Peptidases Leucocitárias/metabolismo , Serina Proteases/análise , Serina Proteases/metabolismo , Inibidores de Serina Proteinase/análise , Inibidores de Serina Proteinase/metabolismo , Estatísticas não Paramétricas , Treponema denticola/isolamento & purificação , Treponema denticola/metabolismoRESUMO
The human Eppin (hEppin) (SPINLW1; Epididymal protease inhibitor) gene was first described and sequenced in 2001, and later identified as an immunocontraceptive target for males in 2004. The expression and function of the mouse eppin (mEppin) gene was first described in 2003, and recent studies have shown that mEppin protein has a similar male contraceptive effect in mice. In this study, we designed a probe to detect mEppin mRNA in frozen sections from the testes of 60-day-old mice as well as in the GC-1, GC-2 and MLTC-1 cell lines, using a hyperbiotinylated oligonucleotide DNA probe. In addition to Sertoli cells, the expression of mEppin mRNA was localized to the spermatogonia, spermatocytes and Leydig cells. Subsequent RT-PCR and Western blot analysis confirmed the results of the in situ hybridization. Immunohistochemistry was performed on corresponding sections of mouse and human testis using an anti-c-kit antibody to detect spermatogonia and an anti-eppin antibody to detect Eppin protein. The expression of mEppin protein was detected in A1-A4 spermatogonia and the expression of hEppin was detected in type A spermatogonia as well as in the earliest preleptotene spermatocytes. The present study demonstrates that the expression of hEppin is similar to that of mEppin, and is localized to differentiated spermatogonia. Moreover, the findings support the hypothesis that mEppin protein is secreted from Sertoli cells and taken up by spermatogonia.
Assuntos
Proteínas Secretadas Inibidoras de Proteinases/análise , Proteínas/análise , RNA Mensageiro/análise , Testículo/metabolismo , Adulto , Animais , Western Blotting , Linhagem Celular , Humanos , Masculino , Camundongos , Camundongos Endogâmicos ICR , Reação em Cadeia da Polimerase , Proteínas Secretadas Inibidoras de Proteinases/genética , Proteínas/genética , Espermatócitos/metabolismo , Espermatogônias/metabolismoAssuntos
Biomarcadores Tumorais/análise , Carcinoma/química , Neoplasias da Próstata/química , Proteínas Secretadas Inibidoras de Proteinases/análise , Carcinoma/mortalidade , Carcinoma/patologia , Carcinoma/cirurgia , Humanos , Imuno-Histoquímica , Estimativa de Kaplan-Meier , Masculino , Estadiamento de Neoplasias , Prostatectomia , Neoplasias da Próstata/mortalidade , Neoplasias da Próstata/patologia , Neoplasias da Próstata/cirurgia , Fatores de Tempo , Resultado do TratamentoRESUMO
PURPOSE: Various studies exploring the potential of the low-molecular-weight serum peptidome have identified proteolytic cleavage products of inter-α-trypsin inhibitor heavy chain-4 (ITIH(4)) as potential markers for different types of cancer, presumably generated by tumor-associated exoproteases. However, further elucidation of the discriminative properties of such peptides requires specific quantitative analytical methods. EXPERIMENTAL DESIGN: Using a recently developed and fully validated liquid chromatography-tandem mass spectrometric method, we have compared absolute serum concentrations of eight peptides derived from ITIH(4 [658-687]) to ([667-687]) (ITIH(4)-30 to -21) between breast cancer patients (n=45) and controls (n=78). Furthermore, serum samples obtained before and after surgical removal of the tumor were analyzed (n=30). RESULTS: The inter-individual variability in measured serum concentrations was high. Nevertheless, most peptides showed a tendency toward elevated levels in the presence of the breast cancer tumor. Significantly increased serum concentrations were observed in the breast cancer group for ITIH(4)-25 (p=0.036) and -29 (p=0.015). Intra-individual comparisons of serum obtained before and after surgery showed significantly decreased serum levels after surgery for seven of the ITIH(4)-derived peptides (p<0.02). CONCLUSIONS AND CLINICAL RELEVANCE: The obtained results particularly suggest potential for these ITIH(4)-derived peptides in the follow-up of breast cancer after surgery.
Assuntos
alfa-Globulinas/análise , Biomarcadores Tumorais/análise , Proteínas Sanguíneas/análise , Neoplasias da Mama/sangue , Glicoproteínas/análise , Fragmentos de Peptídeos/análise , Proteínas Secretadas Inibidoras de Proteinases/análise , Adulto , Idoso , Idoso de 80 Anos ou mais , Cromatografia Líquida/métodos , Feminino , Humanos , Pessoa de Meia-Idade , Neoplasias/sangue , Manejo de Espécimes , Espectrometria de Massas em Tandem/métodosRESUMO
We previously identified four novel cDNA fragments related to human esophageal cancer. One of the fragments was named esophageal cancer related gene 2 (ECRG2). We report here the molecular cloning, sequencing, and expression of the ECRG2 gene. The ECRG2 cDNA comprises a 258 bp nucleotide sequence which encodes for 85 amino acids with a predicted molecular weight of 9.2 kDa. Analysis of the protein sequence reveals the presence at the N terminus of a signal peptide followed by 56 amino acids with a significant degree of sequence similarity with the conserved Kazal domain which characterizes the serine protease inhibitor family. Pulse-chase experiments showed that ECRG2 protein was detected in both cell lysates and culture medium, indicating that the ECRG2 protein was extracellularly secreted after the post-translational cleavage. In vitro uPA/plasmin activity analysis showed the secreted ECRG2 protein inhibited the uPA/plasmin activity, indicating that ECRG2 may be a novel serine protease inhibitor. Northern blot analysis revealed the presence of the major band corresponding to a size of 569 kb throughout the fetal skin, thymus, esophagus, brain, lung, heart, stomach, liver, spleen, colon, kidney, testis, muscle, cholecyst tissues and adult esophageal mucosa, brain, thyroid tissue and mouth epithelia. However, ECRG2 gene was significantly down-regulated in primary esophageal cancer tissues. Taken together, these results indicate that ECRG2 is a novel member of the Kazal-type serine protease inhibitor family and may function as a tumor suppressor gene regulating the protease cascades during carcinogenesis and migration/invasion of esophageal cancer.
Assuntos
Carcinoma de Células Escamosas/genética , Neoplasias Esofágicas/genética , Proteínas Secretadas Inibidoras de Proteinases/genética , Adulto , Sequência de Aminoácidos , Sequência de Bases , Carcinoma de Células Escamosas/patologia , Mapeamento Cromossômico , Clonagem Molecular , Biologia Computacional , DNA Complementar/análise , DNA Complementar/isolamento & purificação , Neoplasias Esofágicas/patologia , Regulação Neoplásica da Expressão Gênica , Genes Neoplásicos , Humanos , Modelos Moleculares , Dados de Sequência Molecular , Invasividade Neoplásica , Proteínas Secretadas Inibidoras de Proteinases/análise , Proteínas Secretadas Inibidoras de Proteinases/química , Proteínas Secretadas Inibidoras de Proteinases/metabolismo , Análise de Sequência de DNA , Inibidores de Serinopeptidase do Tipo KazalRESUMO
To investigate the expression pattern of rat Eppin (epididymal protease inhibitor; official symbol Spinlw1), we detected mRNA transcripts and subsequent protein translation of Eppin in several sorts of tissues by RT-PCR and western blotting. Then immunohistochemistry was performed for more detailed observation. The testicular transcription level was monitored by real-time PCR throughout postnatal development. We found that rat Eppin was specifically expressed in the testis and epididymis. The testicular transcription was slight in neonatal (1-day) and infantile stages (5-, 7- and 10-day). It increased sharply thereafter, with maximum expression level (about 38-fold compared with that of 1-day old rat) detected in prepubertal stage (15-day). Then a slightly declined but stable level (about 20-fold compared with that of 1-day old rat) was kept in pubertal-early adult (30-day) and adult (60-day) stages of postnatal maturation. In the adult rat, EPPIN protein was mainly localized in the elongated spermatids and epididymal epithelial cells. Sperm in the epididymal duct were all covered with EPPIN and its level kept constant during incubation under conditions used to achieve capacitation. Its stage-specific expression in the testis suggests that EPPIN may be important during spermatogenesis especially for the spermatid elongation. The abundant production of epididymal EPPIN indicated indirectly that it might play a role in the function of the epididymis.
Assuntos
Epididimo/química , Inibidores de Proteases/análise , Proteínas Secretadas Inibidoras de Proteinases/análise , Testículo/metabolismo , Animais , Epididimo/metabolismo , Expressão Gênica , Masculino , Ratos , Ratos Sprague-Dawley , Espermatogênese/fisiologia , Testículo/crescimento & desenvolvimentoRESUMO
Hepatocyte growth factor activator inhibitor-1 (HAI-1) is a Kunitz-type serine protease inhibitor that has a broad inhibitory spectrum against serine proteases. This is the first study to investigate the role of HAI-1 and its clinical importance in cervical cancer. We attempted to investigate the inhibitory effects of HAI-1 using cervical carcinoma cell lines SiHa with integrated human papillomavirus (HPV) 16 and HeLa with integrated HPV 18. HAI-1 expression in cervical cancer (n=91) were assessed by immunohistochemistry. HAI-1 was found to be a potential inhibitory effects mediated by reduction of hepsin, matriptase and prostasin expression. This led to apoptosis through a reduction in the levels of Bcl-2, Bcl-xL, MUPP-1 and MAGI-3 in cervical cancer cell lines. There were significant correlations between HAI-1 expression and stage (p=0.013), tumor size (p=0.002), stromal invasion (p<0.001), vaginal invasion (p=0.031), parametrial invasion (p=0.012), lymph-node metastasis (p=0.019), and LVS involvement (p=0.002). The disease-free and overall survival rates of patients exhibiting high HAI-1 expression were significantly higher than those of patients exhibiting low HAI-1 expression (p=0.022 and p=0.011, respectively). The present study proposes that these findings may be considered HAI-1 as a therapeutic target for treatment and identify as a favorable prognostic marker for cancer patients of cervical cancer.
Assuntos
Proteínas Secretadas Inibidoras de Proteinases/fisiologia , Neoplasias do Colo do Útero/mortalidade , Adulto , Idoso , Apoptose , Biomarcadores Tumorais , Ciclo Celular , Proliferação de Células , Feminino , Células HeLa , Humanos , Pessoa de Meia-Idade , Invasividade Neoplásica , Estadiamento de Neoplasias , Prognóstico , Proteínas Secretadas Inibidoras de Proteinases/análise , Taxa de Sobrevida , Neoplasias do Colo do Útero/química , Neoplasias do Colo do Útero/patologiaRESUMO
Cerebrospinal fluid (CSF) is a promising source of biomarkers in clinically isolated syndrome (CIS), which frequently presents as a first episode of multiple sclerosis (MS). Using the two-dimensional difference in gel electrophoresis (2-D DIGE), we compared CSF samples from patients with CIS that remained CIS (CIS-CIS, n=8) over a follow-up time of 2 years and from patients with CIS that developed definite MS of the relapsing-remitting subtype (CIS-RRMS, n=8) over the same period. Protein spots that showed significant differences between patients and controls were selected for further analysis by MALDI-TOF mass spectrometry. For validation of identified spots ELISA experiments were performed. We identified one protein that was upregulated in CIS-RRMS (serin peptidase inhibitor) and eight proteins (alpha-1-B-glycoprotein, Fetuin-A, apolipoprotein A4, haptoglobin, human Zinc-alpha-2-glycoprotein (ZAG), Retinol-binding protein, superoxid dismutase 1, transferrin) that were down-regulated in CIS-RRMS vs. CIS-CIS. For Fetuin-A, our findings could be confirmed by ELISA. The pathophysiological role as well as clinical relevance of these candidate proteins in CIS remains to be further clarified by future studies.
Assuntos
Doenças Desmielinizantes/líquido cefalorraquidiano , Doenças Desmielinizantes/diagnóstico , Esclerose Múltipla/líquido cefalorraquidiano , Esclerose Múltipla/diagnóstico , Proteoma/análise , Proteômica/métodos , Adolescente , Adulto , Biomarcadores/análise , Biomarcadores/líquido cefalorraquidiano , Proteínas do Líquido Cefalorraquidiano/análise , Proteínas do Líquido Cefalorraquidiano/metabolismo , Progressão da Doença , Eletroforese em Gel Bidimensional , Ensaio de Imunoadsorção Enzimática , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Esclerose Múltipla Recidivante-Remitente/líquido cefalorraquidiano , Esclerose Múltipla Recidivante-Remitente/diagnóstico , Proteínas Secretadas Inibidoras de Proteinases/análise , Proteínas Secretadas Inibidoras de Proteinases/líquido cefalorraquidiano , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Adulto JovemRESUMO
Recent studies have suggested that matriptase, a transmembrane serine protease and its cognate inhibitor hepatocyte growth factor activator inhibitor-1 (HAI-1) are important in the progression of many cancers. Limited quantitative data are available on these proteins in prostate cancer. To validate the roles of matriptase and HAI-1 in prostate cancer and its progression, a prostate cancer tissue microarray was constructed. The tissue microarray includes 41 localized prostate cancers (Pca_local), 18 aggressive prostate cancers, 18 metastatic prostate cancers, 24 benign prostate hyperplasias, 18 high-grade intraepithelial neoplasias (HGPIN), and 41 benign prostate tissues. The cellular expression levels of matriptase and HAI-1 were quantified using automated quantitative analysis. We found that matriptase expression levels were significantly higher in Pca_local (P<0.0001) and HGPIN (P<0.05) compared with benign prostate tissue. Matriptase levels were significantly decreased in metastatic cancer when compared with all other tissue types (P<0.05). Compared with benign prostate tissue, HAI-1 expression levels were significantly higher in all proliferative prostate diseases (benign prostate hyperplasia, HGPIN, localized and aggressive cancers, and metastases) (P<0.001); yet, no significant differences were found in HAI-1 expression levels among the diseased tissue types. These results suggest that an increase of matriptase may be useful as a marker for detection of Pca_local, whereas a decrease of matriptase expression may signal prostate cancer progression. HAI-1 seems to be a marker of prostate epithelial cell proliferation.
Assuntos
Neoplasias da Próstata/patologia , Proteínas Secretadas Inibidoras de Proteinases/análise , Serina Endopeptidases/análise , Análise Serial de Tecidos/métodos , Automação , Proliferação de Células , Diagnóstico por Computador , Progressão da Doença , Células Epiteliais/patologia , Humanos , Masculino , Metástase Neoplásica/patologia , Neoplasias da Próstata/diagnóstico , Análise Serial de Tecidos/instrumentaçãoRESUMO
Matriptase, a type 2 transmembrane serine protease, is predominately expressed by epithelial and carcinoma cells in which hepatocyte growth factor activator inhibitor 1 (HAI-1), a membrane-bound, Kunitz-type serine protease inhibitor, is also expressed. HAI-1 plays dual roles in the regulation of matriptase, as a conventional protease inhibitor and as a factor required for zymogen activation of matriptase. As a consequence, activation of matriptase is immediately followed by HAI-1-mediated inhibition, with the activated matriptase being sequestered into HAI-1 complexes. Matriptase is also expressed by peripheral blood leukocytes, such as monocytes and macrophages; however, in contrast to epithelial cells, monocytes and macrophages were reported not to express HAI-1, suggesting that these leukocytes possess alternate, HAI-1-independent mechanisms regulating the zymogen activation and protease inhibition of matriptase. In the present study, we characterized matriptase complexes of 110 kDa in human milk, which contained no HAI-1 and resisted dissociation in boiling SDS in the absence of reducing agents. These complexes were further purified and dissociated into 80-kDa and 45-kDa fragments by treatment with reducing agents. Proteomic and immunological methods identified the 45-kDa fragment as the noncatalytic domains of matriptase and the 80-kDa fragment as the matriptase serine protease domain covalently linked to one of three different secreted serpin inhibitors: antithrombin III, alpha1-antitrypsin, and alpha2-antiplasmin. Identification of matriptase-serpin inhibitor complexes provides evidence for the first time that the proteolytic activity of matriptase, from those cells that express no or low levels of HAI-1, may be controlled by secreted serpins.
Assuntos
Leite Humano/metabolismo , Serina Endopeptidases/metabolismo , Serpinas/metabolismo , Sequência de Aminoácidos , Antitrombina III/análise , Antitrombina III/isolamento & purificação , Antitrombina III/metabolismo , Western Blotting , Cromatografia Líquida , Eletroforese em Gel de Poliacrilamida , Humanos , Espectrometria de Massas , Leite Humano/química , Dados de Sequência Molecular , Proteínas Secretadas Inibidoras de Proteinases/análise , Proteínas Secretadas Inibidoras de Proteinases/isolamento & purificação , Proteínas Secretadas Inibidoras de Proteinases/metabolismo , Serina Endopeptidases/análise , Serina Endopeptidases/isolamento & purificação , Serpinas/análise , Serpinas/isolamento & purificação , alfa 1-Antitripsina/análise , alfa 1-Antitripsina/isolamento & purificação , alfa 1-Antitripsina/metabolismo , alfa 2-Antiplasmina/análise , alfa 2-Antiplasmina/isolamento & purificação , alfa 2-Antiplasmina/metabolismoRESUMO
Inter-alpha-trypsin inhibitors (ITIs) are protease inhibitors stabilizing the extracellular matrix. ITIs consist of one light (bikunin) and two heavy chains (ITIHs). We have recently characterized ITIH5, a novel member of the ITIH gene family, and showed that its messenger RNA is lost in a high proportion of breast tumours. In the present study, an ITIH5-specific polyclonal antibody was generated, validated with western blot and used for immunohistochemical analysis on a tissue microarray; ITIH5 was strongly expressed in epithelial cells of normal breast (n=11/15), while it was lost or strongly reduced in 42% (92/217) of invasive breast cancers. ITIH5 expression in invasive carcinomas was associated with positive expression of oestrogen receptor (P=0.008) and histological grade (P=0.024). Correlation of ITIH5 expression with clinical outcome revealed that patients with primary tumours retaining abundant ITIH5 expression had longer recurrence-free survival (RFS; P=0.037) and overall survival (OS; P=0.044), compared to those with reduced expression (mean RFS: 102 vs 78 months; mean OS: 120 vs 105 months). Methylation-specific PCR analysis frequently showed strong methylation of the ITIH5 promoter in primary breast tumours (41%, n=109) and breast cancer cell lines (n=6). Methylation was significantly associated with mRNA loss (P<0.001; n=39), and ITIH5 expression was induced after treatment of tumour cell lines with the demethylating agent 5-aza-2'-deoxycytidine. Moreover, ITIH5 promoter methylation was significantly associated with reduced OS (P=0.008). The cellular function of ITIH5 was evaluated by forced expression of a full-length ITIH5 complementary DNA in the breast cancer cell line MDA-MB-231, which does not endogenously express ITIH5. ITIH5-expressing clones showed a 40% reduced proliferation rate compared to mock-transfected cells. Overall, these data show that promoter methylation-mediated loss of ITIH5 expression is associated with unfavourable outcome in breast cancer patients, and thus ITIH5 could be used as a prognostic marker, although this marker is not multivariate independent due to its close association with ER expression. Our data indicate that ITIH5 is a candidate class II tumour suppressor gene and could be involved in tumour progression, invasion and metastasis, as its absence is associated with increased proliferation rates and a prognostic value indicating poor clinical outcome.